吉林敖东：延吉药业收到甲硝唑芬布芬胶囊的药品补充申请批准通知书

Core Viewpoint - Jilin Aodong Pharmaceutical Group Co., Ltd. has received approval from the National Medical Products Administration for the marketing authorization of "Metronidazole Fenbufen Capsules" through its subsidiary, Yanji Pharmaceutical [1] Group 1 - The marketing authorization holder for the drug has been changed from Harbin Huarui Biochemical Pharmaceutical Co., Ltd. to Jilin Aodong Pharmaceutical Group Yanji Co., Ltd. [1] - The drug approval number remains unchanged, indicating continuity in regulatory compliance [1] - The transfer of the drug includes the production site, formulation, production process, and quality standards, all of which remain consistent with the original product [1]